-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.O2.6 617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Single Cell Profiling and Novel molecular Markers

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
AML, Leukemia, Diseases, Combinations, Biological Processes, immune cells, Technology and Procedures, Young Adult, Cell Lineage, Lymphoid Malignancies, Study Population, Myeloid Malignancies, Clinically relevant, genetic profiling, mass cytometry, microenvironment, RNA sequencing
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Moderators:
Kenichi Yoshida, MD, PhD, Wellcome Sanger Institute and Anupriya Agarwal, PhD, Oregon Health & Science University
Disclosures:
No relevant conflicts of interest to declare.
7:30 AM

Beena E Thomas1*, Pruthvi Perumalla, MS2*, Swati S Bhasin, PhD3*, Debasree Sarkar, PhD4*, Bhakti Dwivedi, PhD5*, Sunita I Park, M.D.6*, Deborah DeRyckere, BS, PhD7, Curtis J. Henry, PhD8, Sunil S. Raikar, MD9, Christopher C. Porter, MD10,11, Melinda Pauly, MD11,12*, Ryan J Summers, MD13, Sharon M. Castellino, MD, MSc14, Daniel S. Wechsler, MD, PhD15, Douglas K Graham, MD, PhD16 and Manoj Bhasin, PhD1*

1Emory School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, GA
2Department of Biomedical Informatics, Emory School of Medicine, Atlanta, GA
3Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Atlanta, GA
4Emory University, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Atlanta, GA
5Winship Cancer Insitute , Emory School of Medicine, Atlanta, GA
6Department of Pathology, Children's Healthcare of Atlanta, Atlanta, GA
7Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, GA
8Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
9Aflac Cancer and Blood Disorders Center, Emory University/Children's Healthcare of Atlanta, Atlanta, GA
10Pediatrics, Emory University, Atlanta, GA
11Department of Pediatrics, Emory University, Atlanta, GA
12Department of Pediatrics, Children’s Healthcare of Atlanta, Atlanta, GA
13Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory, Atlanta, GA
14Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA
15Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA
16Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, GA

7:45 AM

Shuting Jiang1*, Fuhong He, PhD1*, Li Gao, MD2*, Aili Chen, PhD1*, Yixin Hu, MD2*, Liyan Fan, MD2*, Lin Zhang, MS1,3*, Yongping Zhang2*, Haiyang Hu1,3*, Dan Liu, MS1*, Zihan Zhou1,3*, Yanxun Su1,3*, Lei Qin1,3*, Jun Lu, MD2*, Peifang Xiao, MD2*, Raul Ribeiro, MD4, Shaoyan Hu, MD, PhD2 and Qian-fei Wang, PhD1,3

1CAS Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences(China National Center for Bioinformation), Beijing, China
2Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
3University of Chinese Academy of Sciences, Beijing, China
4Department of Oncology and Global Medicine, International Outreach Program, St. Jude Children's Research Hospital, Memphis, TN

8:00 AM

Muharrem Muftuoglu, MD1, Zoe Alaniz, BS1*, Duncan Mak, BSc, MPhil1*, Angelique J. Lin, MS2*, Jared K. Burks, PhD1*, Bing Z Carter, PhD3 and Michael Andreeff, MD, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
3Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

8:15 AM

Jayakumar Vadakekolathu, PhD1*, Tung On Yau1*, Heidi Altmann, PhD2*, Sarah E. Church, PhD3*, Hanna A Knaus, MD4*, Mark D. Minden5, Jan K Davidson-Moncada, MD, PhD6, Sarah K Tasian, MD7, Martin Bornhäuser, MD2*, Ivana Gojo, MD8, Leo Luznik, MD8 and Sergio Rutella, MD, PhD, FRCPath1,9

1John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
2Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
3NanoString Technologies, Inc., Everett, WA
4Medical University of Vienna, Vienna, Vienna, AUT
5Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
6MacroGenics, Inc., Washington, DC
7Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
9Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, United Kingdom

8:30 AM

Hassan Awada, MD1, Arda Durmaz2*, Carmel Gurnari, MD3*, Ashwin Kishtagari, MBBS1, Manja Meggendorfer, PhD4, Cassandra M. Kerr, MS5*, Teodora Kuzmanovic5*, Jibran Durrani, MD1*, Yasunobu Nagata, MD, PhD5*, Tomas Radivoyevitch, PhD5,6*, Anjali S Advani, MD7, Farhad Ravandi, MBBS8, Hetty E. Carraway, MD, MBA9, Aziz Nazha, MD10, Claudia Haferlach, MD11, Yogenthiran Saunthararajah, MD12, Jacob Scott, MD5*, Valeria Visconte, PhD1, Hagop M. Kantarjian, MD13, Tapan M. Kadia, MD8, Mikkael A. Sekeres10, Torsten Haferlach, MD14 and Jaroslaw P. Maciejewski, MD, PhD5

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Translational hematology and Oncology research, Taussic Cancer Center, Cleveland Clinic, Cleveland
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland
4MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
7Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
10Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland
11MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany
12Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
13University of Texas MD Anderson Cancer Center, Houston, TX
14MLL Munich Leukemia Laboratory, Munich, Germany

8:45 AM

Hidemasa Matsuo1*, Kenichi Yoshida, MD, PhD2, Kana Nakatani3*, Yutarou Harata4*, Moe Higashitani5*, Yuri Ito6*, Yasuhiko Kamikubo4*, Yusuke Shiozawa, MD, PhD7*, Yuichi Shiraishi, PhD8*, Kenichi Chiba9*, Hiroko Tanaka, BA10*, Ai Okada11*, Yasuhito Nannya, MD, PhD12, June Takeda, MD13*, Hiroo Ueno, MD, PhD13*, Nobutaka Kiyokawa, MD, PhD14*, Daisuke Tomizawa, MD, PhD15, Takashi Taga, MD, PhD16*, Akio Tawa, MD, PhD17*, Satoru Miyano, PhD18*, Manja Meggendorfer, PhD19, Claudia Haferlach, MD20, Seishi Ogawa, MD, PhD21 and Souichi Adachi, MD, PhD4

1Department of Human Health Sciences, Kyoto University, Kizugawa, KYO, Japan
2Kyoto Univeristy, Kyoto, Japan
3Department of Human Health Sciences, Kyoto University, Kyoto-Shi, Japan
4Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, JPN
6Kyoto University, Kyoto, Japan
7Department of Pediatrics, The University of Tokyo, Tokyo, Japan
8Center for Cancer Genomics and Advanced Therapeutics, National Cancer Center Research Institute, Tokyo, Japan
9Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan
10Laboratory of DNA Information Analysis, Human Genome Center, The University of Tokyo, Tokyo, Japan
11Laboratory of DNA Information Science, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
12Department of Pathology and Tumor Biology, Kyoto University, Kyoto City, Japan
13Department of Pathology and Tumor Biology, Kyoto University, Kyoto, KYO, Japan
14Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan
15Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
16Department of Pediatrics, Shiga University of Medical Science, Ohtsu, Japan
17Higashiosaka Aramoto Hiewa Clinic, Higashiosaka, Japan
18Department of Integrated Data Science, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
19MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
20MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany
21Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

*signifies non-member of ASH